FDA approves first generic Xeloda
September 17, 2013Sales and Marketing FDA, Roche, Teva, Xeolda, breast cancer, colorectal cancer
J&J’s prescription drugs unit hit by recall
September 17, 2013Manufacturing and Production J&J, JJ, Risperdal, Tylenol, recalls
Yervoy setback in prostate cancer
September 16, 2013Research and Development, Sales and Marketing BMS, Yervoy, melanoma, prostate cancer
Bayer faces China investigation
September 16, 2013Medical Communications, Sales and Marketing Bayer, China, corruption
Now China’s pharma firms under spotlight
September 13, 2013Medical Communications, Sales and Marketing Chia Tai Tianqing Pharmaceutical, China, bribery, corruption, pharma
The net cast out by Chinese authorities over the country’s pharma industry may be about to ensnare its first domestic …
Fake drugs warning from pharma
September 13, 2013Manufacturing and Production, Sales and Marketing EFPIA, WHO, counterfeit, viagra
Pharma has warned that not enough is being done to protect consumers from counterfeit medicines – particularly those bought online …
Quintiles president to chair Idis
September 13, 2013Manufacturing and Production, Research and Development, Sales and Marketing IDIS, Quintiles, thomis
Former Quintiles president Jeff Thomis has been appointed to the role of chairman at Idis. In his new role, Thomis …
Bayer partners with US academics
September 13, 2013Research and Development, Sales and Marketing Bayer, Cancer, broad, oncology
Bayer HealthCare and a prestigious US academic institution have signed a five-year deal to find new oncology treatments. The German …
Hunt: GPs to care for elderly
September 12, 2013Sales and Marketing GP, Hunt, NHS, elderly
Health secretary Jeremy Hunt says that GPs are in line to become the named clinician responsible for elderly people’s care …
Sanofi withdraws lixisenatide US application
September 12, 2013Sales and Marketing FDA, Lixisenatide, Sanofi, diabetes, elixa
In a blow to its diabetes pipeline, Sanofi has withdrawn a new drug application (NDA) for lixisenatide in the US …
Latest content
EnteroBiotix appoints former GSK Chief Medical Officer to board
AI: an early warning system for patient safety
Highlighting the value of lab research for healthcare innovation
